News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
730,525 Results
Type
Article (47091)
Company Profile (363)
Press Release (683071)
Section
Business (215544)
Career Advice (2330)
Deals (37918)
Drug Delivery (106)
Drug Development (84400)
Employer Resources (178)
FDA (16794)
Job Trends (15727)
News (364719)
Policy (34964)
Tag
Academia (2725)
Alliances (52327)
Alzheimer's disease (1307)
Approvals (16745)
Artificial intelligence (166)
Bankruptcy (373)
Best Places to Work (11938)
Biotechnology (235)
Breast cancer (194)
Cancer (1426)
Cardiovascular disease (119)
Career advice (1956)
Cell therapy (303)
Clinical research (67369)
Collaboration (513)
Compensation (266)
COVID-19 (2676)
C-suite (116)
Data (1417)
Diabetes (186)
Diagnostics (6406)
Earnings (88802)
Employer resources (156)
Events (116065)
Executive appointments (416)
FDA (17501)
Funding (447)
Gene therapy (212)
GLP-1 (663)
Government (4654)
Healthcare (19449)
Infectious disease (2772)
Inflammatory bowel disease (120)
Interviews (368)
IPO (16913)
Job creations (4205)
Job search strategy (1670)
Layoffs (459)
Legal (8657)
Lung cancer (208)
Manufacturing (229)
Medical device (13701)
Medtech (13706)
Mergers & acquisitions (21168)
Metabolic disorders (497)
Neuroscience (1651)
NextGen Class of 2024 (6853)
Non-profit (4684)
Northern California (1720)
Obesity (284)
Opinion (223)
Patents (127)
People (59942)
Pharmaceutical (103)
Phase I (20869)
Phase II (29582)
Phase III (22221)
Pipeline (523)
Postmarket research (2788)
Preclinical (8939)
Radiopharmaceuticals (248)
Rare diseases (284)
Real estate (6431)
Regulatory (23176)
Research institute (2466)
Resumes & cover letters (386)
Southern California (1491)
Startups (3828)
United States (15685)
Vaccines (601)
Weight loss (209)
Date
Today (31)
Last 7 days (531)
Last 30 days (2540)
Last 365 days (36623)
2024 (36465)
2023 (41232)
2022 (52488)
2021 (57123)
2020 (55769)
2019 (48702)
2018 (36861)
2017 (34145)
2016 (33884)
2015 (39904)
2014 (33778)
2013 (28902)
2012 (31064)
2011 (31685)
2010 (29873)
Location
Africa (853)
Arizona (209)
Asia (42215)
Australia (6870)
California (3899)
Canada (1468)
China (319)
Colorado (179)
Connecticut (185)
Europe (91209)
Florida (544)
Georgia (137)
Illinois (409)
Indiana (235)
Maryland (658)
Massachusetts (3071)
Michigan (182)
Minnesota (297)
New Jersey (1138)
New York (1113)
North Carolina (800)
Northern California (1720)
Ohio (150)
Pennsylvania (941)
South America (1237)
Southern California (1491)
Texas (567)
Utah (112)
Washington State (413)
730,525 Results for "alantos pharmaceuticals holding inc acquired by parexel international".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Poseida Therapeutics, Inc. Announces Agreement to be Acquired by Roche Holdings, Inc.
November 26, 2024
·
9 min read
Business
Parexel and Palantir Expand Collaboration to Accelerate Clinical Data Delivery and Power Clinical Outcomes for Patients
Parexel, one of the world’s largest clinical research organizations (CROs) providing the full range of Phase I to IV clinical development services, and Palantir Technologies Inc.
April 25, 2024
·
6 min read
Deals
Future Pak Issues Enhanced and Final Proposal to Acquire Vanda Pharmaceuticals Inc.
Future Pak, LLC and its affiliates announced that it has submitted a final attempt to engage with Vanda Pharmaceuticals Inc. in a good faith effort to acquire all outstanding shares of Vanda.
June 13, 2024
·
4 min read
Press Releases
Acumen Health Holdings (“Acumen”) to Acquire the Avenova brand from NovaBay Pharmaceuticals
September 20, 2024
·
2 min read
BioMidwest
Bexion Pharmaceuticals, Inc. to Present at BIO International Convention 2024
Bexion Pharmaceuticals, Inc. announced that the Company will present at the 2024 Biotechnology Innovation Organization International Convention taking place June 3-6, 2024, in San Diego, California.
May 31, 2024
·
2 min read
Press Releases
Eton Pharmaceuticals, Inc to Acquire Increlex® (mecasermin injection) from Ipsen
October 3, 2024
·
8 min read
Press Releases
Bloom Burton & Co. Inc. Announces Changes to Holdings in Satellos Bioscience Inc.
December 20, 2024
·
2 min read
Press Releases
TuHURA Biosciences, Inc. Enters into Definitive Merger Agreement to Acquire Kineta, Inc.
December 12, 2024
·
19 min read
Press Releases
Assertio Holdings, Inc. Appoints Mark Reisenauer to Its Board of Directors
December 18, 2024
·
4 min read
BioCapital
Vanda Pharmaceuticals Confirms Receipt of Unsolicited, Non-Binding Indication of Interest from Cycle Group Holdings Ltd.
Vanda Pharmaceuticals Inc. confirmed that it has received an unsolicited, non-binding indication of interest from Cycle Group Holdings Ltd. to acquire the Company for $8.00 per share in cash.
June 6, 2024
·
3 min read
1 of 73,053
Next
